Saint Cyr sur Loire, France

Jean-Stëphane Julien

This inventor holds 1 USPTO granted patent. Top assignee: Bioprojet. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Stëphane Julien. Retrieved from https://idiyas.com/inventor/jean-stëphane-julien

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jean-Stëphane Julien

Introduction

Jean-Stëphane Julien is a notable inventor based in Saint Cyr sur Loire, France. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of enkephalinase inhibitors. His work is aimed at improving treatment options for various medical conditions.

Latest Patents

Jean-Stëphane Julien holds one patent titled "Form of administration of enkephalinase inhibitor." This invention relates to a new formulation of an enkephalinase inhibitor, such as racecadotril or dexecadotril. The patent outlines the process for preparing this formulation and its application in treating diarrhea.

Career Highlights

Throughout his career, Julien has been associated with Bioprojet, a company focused on innovative pharmaceutical solutions. His expertise in the development of enkephalinase inhibitors has positioned him as a key figure in this specialized area of research.

Collaborations

Jean-Stëphane Julien has collaborated with notable colleagues, including Marc Maury and Jeanne-Marie Lecomte. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Jean-Stëphane Julien's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions, particularly in the formulation of enkephalinase inhibitors, highlight the importance of research and collaboration in developing effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…